Advertisement
Company's Conference Call and Webcast
Management will host a conference call Tuesday, September 9, 2008 at 2:00PM Pacific (5:00 PM Eastern) to review the fourth quarter and fiscal year endresults.
Advertisement
The call can be accessed by dialing 1-800-860-2442 within the U.S. or1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Dr. WilliamOsgood, Chief Executive Officer and Matthew Plavan, Chief Financial Officerwill host the call to discuss the year end, quarter results and othercorporate events, followed by a Q&A session. Participants are asked to callthe assigned number approximately 5 minutes before the conference call begins.
To listen to the audio webcast of the call during or after the event,please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.
Replay
A replay of the conference call will be available two hours after the callfor the following five business days by dialing 1-877-344-7529 within the U.S.or 1-412-317-0088 outside the U.S. and entering the following account numberwhen prompted '385107'.
About ThermoGenesis Corp.
ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplierof innovative products and services that process and store adult stem cellsfor treatment of disease and injury.
This press release contains forward-looking statements, and suchstatements are made pursuant to the safe harbor provisions of the PrivateSecurities Litigation Reform Act of 1995. These statements involve risks anduncertainties that could cause actual outcomes to differ materially from thosecontemplated by the forward-looking statements. Several factors, includingtiming of FDA approvals, changes in customer forecasts, our failure to meetcustomers' purchase order and quality requirements, supply shortages,production delays, changes in the markets for customers' products,introduction timing and acceptance of our new products scheduled for fiscalyear 2009, and introduction of competitive products and other factors beyondour control, could result in a materially different revenue outcome and/or inour failure to achieve the revenue levels we expect for fiscal 2009. A morecomplete description of these and other risks that could cause actual eventsto differ from the outcomes predicted by our forward-looking statements is setforth under the caption "Risk Factors" in our annual report on Form 10-K andother reports we file with the Securities and Exchange Commission from time totime, and you should consider each of those factors when evaluating theforward-looking statements.ThermoGenesis Corp. Web site: http://www.thermogenesis.com Contact: Investor Relations +1-916-858-5107, or [email protected]
SOURCE ThermoGenesis Corp.